Workflow
迈威(上海)生物科技股份有限公司关于公司董事长兼总经理收到行政处罚决定书的公告

Core Viewpoint - The announcement details the administrative penalty imposed on Liu Datao, the Chairman and General Manager of Maiwei (Shanghai) Biotechnology Co., Ltd., for engaging in short-term trading of the company's stock, which violates the Securities Law of the People's Republic of China [1][2]. Summary by Sections Administrative Penalty Details - Liu Datao was found to have bought 976,567 shares of "Maiwei Biotechnology" for a total of 19,297,719.97 yuan and sold 634,265 shares for 13,883,564.69 yuan between January 18, 2022, and July 18, 2022 [2]. - His actions were classified as violations under Article 44 and Article 189 of the Securities Law, leading to a warning and a fine of 600,000 yuan [2]. Compliance and Disclosure - The company emphasizes its commitment to comply with relevant laws and regulations, ensuring timely information disclosure [4]. - The administrative penalty pertains solely to Liu Datao and is not expected to significantly impact the company's daily operations [3].